Bacitracin

Generic Name
Bacitracin
Brand Names
Baciguent, Baciject, Cortisporin, Diosporin, Diphen, Neo-polycin, Neo-polycin HC, Neosporin Ointment, Neosporin Plus Maximum Strength, Neosporin Solution, Polycin-B, Polysporin, Procomycin, Rash Relief Antibacterial, Triple Antibiotic
Drug Type
Small Molecule
Chemical Formula
C66H103N17O16S
CAS Number
1405-87-4
Unique Ingredient Identifier
DDA3RRX0P7
Background

Bacitracin is a combination of at least 9 bacitracins. 60-80% of commercially prepared bacitracin is bacitracin A. The bacillus that produces bacitracin was first isolated from a knee scrape in 1945 from the knee wound of a child named Margaret Tracy.

Bacitracin was granted FDA approval on 29 July 1948.

Indication

Bacitracin is indicated in topical formulations for acute and chronic localized skin infections. Occasionally, it is also used intramuscularly for infantile streptococcal pneumonia and empyema. Bacitracin is also formulated as an ointment with neomycin and polymyxin B for over the counter use. A bacitracin ointment formulated with neomycin and polymyxin B al...

Associated Conditions
Acne, Bacterial Infections of the Intestine, Empyema, Eye Infections, Infection, Inflammatory Reaction caused by Acne, Ocular Inflammatory Disease, Pneumonia, Skin Ulcer, Wound, Wound Infections, Corticosteroid-responsive dermatoses, Infection in minor cuts, scrapes, or burns
Associated Therapies
-
Clinical Trials
Related News

The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown

Phase 4
Completed
Conditions
Skin Infection
Interventions
Drug: Medicinal honey
Drug: Bacitracin
First Posted Date
2019-04-26
Last Posted Date
2022-08-30
Lead Sponsor
Ascension South East Michigan
Target Recruit Count
17
Registration Number
NCT03929224
Locations
🇺🇸

Ascension Providence Hospital, Novi Campus, Novi, Michigan, United States

Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy

First Posted Date
2017-07-11
Last Posted Date
2019-02-08
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
19
Registration Number
NCT03213249
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns

First Posted Date
2016-02-03
Last Posted Date
2024-07-10
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
20
Registration Number
NCT02673229
Locations
🇺🇸

University of Kansas Medical Center, Kansas City, Kansas, United States

Comparison of Wound Bed Establishment in Facial Burns

Phase 4
Completed
Conditions
Burns
Interventions
Drug: Enzymatic agent
Drug: Bacitracin
First Posted Date
2012-08-17
Last Posted Date
2017-08-28
Lead Sponsor
University of Louisville
Target Recruit Count
10
Registration Number
NCT01668030
Locations
🇺🇸

UofL Health Care, Louisville, Kentucky, United States

The Relationship of Hemoglobin A1c and Diabetic Wound Healing

First Posted Date
2011-05-09
Last Posted Date
2017-12-12
Lead Sponsor
Susan Hassenbein
Target Recruit Count
2
Registration Number
NCT01350102
Locations
🇺🇸

Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge

Phase 2
Completed
Conditions
Paranasal Sinus Disease
Interventions
Drug: Bacitracin
First Posted Date
2010-10-18
Last Posted Date
2017-05-31
Lead Sponsor
Steward St. Elizabeth's Medical Center of Boston, Inc.
Target Recruit Count
226
Registration Number
NCT01222832
Locations
🇺🇸

St. Elizabeth's Medical Center, Brighton, Massachusetts, United States

Pilot Study To Evaluate A Pharmacologically Active Nasal Sponge Following Endoscopic Sinus Surgery

First Posted Date
2008-06-26
Last Posted Date
2012-04-13
Lead Sponsor
Lahey Clinic
Registration Number
NCT00705354
Locations
🇺🇸

Lahey Clinic, Inc., Burlington, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy